Nuclear Radiology: Page 2

French researchers offer novel theory for long COVID brain fog
By Will Morton
A group from Marseille University Hospital has provided a fresh explanation for long COVID brain fog. The team's concept is based on a visual brain pattern they discovered on patients' PET scans.
October 22, 2023
Does a novel PET system for prostate cancer have real clinical potential?
By Will Morton
A recently built dedicated PET scanner may improve the detection of prostate cancer and could ultimately reduce invasive patient biopsies to confirm disease, according to a research team in Bologna, Italy.
October 15, 2023
GE HealthCare and Sofie sign deal to develop FAPI-PET tracers
By AuntMinnieEurope.com staff writers
GE HealthCare has established a licensing agreement to commercialize two fibroblast activated protein inhibitor (FAPI)-PET radiotracers developed by Sofie Biosciences for cancer imaging.
October 12, 2023
Eckert & Ziegler sign deal with PharmaLogic for Ac-225 supply
By AuntMinnieEurope.com staff writers
Eckert & Ziegler and PharmaLogic Holdings have signed a reservation agreement for the supply of the therapeutic radioisotope Actinium-225 (Ac-225).
October 9, 2023
2019 12 19 17 57 7265 Business Man Handshake 400
Technegas receives regulatory approval for lung scans
By AuntMinnieEurope.com staff writers
The U.S. Food and Drug Administration (FDA) has approved Technegas for use in nuclear medicine ventilation/perfusion lung scans to diagnose pulmonary embolism.
October 5, 2023
2018 04 24 20 24 4264 Isotope 400
IAEA extends global reach of Rays of Hope cancer initiative
By Will Morton
Rays of Hope -- the flagship cancer project from the International Atomic Energy Agency (IAEA) -- has established new "anchor centers" in five countries. The main aim is to increase access to diagnosis and treatment for cancer patients, the agency says.
October 1, 2023
2020 04 28 15 13 5329 Iaea 400
Eckert & Ziegler sign agreement with Point Biopharma for Lu-177 supply
By AuntMinnieEurope.com staff writers
Eckert & Ziegler AG recently signed an agreement with Point Biopharma Global for the supply of carrier-free lutetium-177 (Lu-177).
September 27, 2023
2021 04 27 21 30 4093 Business Contract Signing 400
Imaging plays central role in tackling immunotherapy complications
By Philip Ward
The use of immune-mediated treatment of cancer is leading to dramatic improvements in patient outcome, but it also has new toxicity profiles, making it vital to recognize imaging manifestations of adverse effects, award-winning Spanish researchers have reported.
September 26, 2023
Rare finding detected on PSMA-PET: A nonprostatic lung tumor
By Will Morton
A group in Australia has described a rare finding during a prostate cancer restaging PET/CT scan -- a pulmonary tumor embolism.
September 26, 2023
Which PET radiotracer tends to work best for prostate cancer imaging?
By Will Morton
Subtle differences in how prostate-specific membrane antigen-PET radiotracers perform in patients prior to Pluvicto treatment may determine which ones become the future tracers of choice, according to a research team in Germany.
September 25, 2023
2020 10 20 23 49 8936 3 D Rendered Pet Machine 400
FAPI-PET/CT may improve treatment of cancer patients
By Will Morton
Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approach for detecting cancer -- may further improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers.
September 19, 2023
Maximum intensity projection of Ga 68 FAPI PET.
Curasight promotes PET study in brain cancer patients
By AuntMinnieEurope.com staff writers
Curasight has highlighted recently presented results of a phase II study of its gallium-68 NOTA-AE105 PET tracer in patients with brain cancer.
September 17, 2023
2016 08 26 09 42 23 633 Brain Headache 400
Previous Page
Page 2 of 90
Next Page